학술논문
Efficacy of Lebrikizumab in Patients With Atopic Dermatitis and Atopic Comorbidities: Pooled Results From Two Phase 3 Monotherapy Randomized, Double-Blind, Placebo-Controlled 16-Week Studies (ADvocate1 and ADvocate2)
Document Type
Abstract
Author
Source
In The Journal of Allergy and Clinical Immunology February 2023 151(2) Supplement:AB148-AB148
Subject
Language
ISSN
0091-6749